Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
831,964
Value
$518.8M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026831,964$518.8M<0.1%−686,228−45.2%ReducedHolders
Q1 20261,518,192$1.17B0.1%−801,374−34.5%ReducedHolders
Q4 20252,319,566$1.79B0.1%+383,731+19.8%AddedHolders
Q3 20251,935,835$1.09B0.1%−1,391,216−41.8%ReducedHolders
Q2 20253,327,051$1.75B0.1%−4,271,533−56.2%ReducedHolders
Q1 20257,598,584$4.82B0.3%−600,995−7.3%ReducedHolders
Q4 20248,199,579$5.84B0.3%−2,163,122−20.9%ReducedHolders
Q3 202410,362,701$10.9B0.7%−286,773−2.7%ReducedHolders
Q2 202410,649,474$11.2B0.7%−144,598−1.3%ReducedHolders
Q1 202410,794,072$10.4B0.7%+476,657+4.6%AddedHolders
Q4 202310,317,415$9.06B0.7%+476,523+4.8%AddedHolders
Q3 20239,840,892$8.10B0.7%+669,517+7.3%AddedHolders
Q2 20239,171,375$6.59B0.6%−268,721−2.8%ReducedHolders
Q1 20239,440,096$7.76B0.7%−1,656,895−14.9%ReducedHolders
Q4 202211,096,991$8.01B0.8%+287,245+2.7%AddedHolders
Q3 202210,809,746$7.45B0.8%+633,547+6.2%AddedHolders
Q2 202210,176,199$6.02B0.6%+193,175+1.9%AddedHolders
Q1 20229,983,024$6.97B0.6%−79,943−0.8%ReducedHolders
Q4 202110,062,967$6.35B0.5%−1,004,984−9.1%ReducedHolders
Q3 202111,067,951$6.70B0.5%+157,257+1.4%AddedHolders
Q2 202110,910,694$6.09B0.5%−25,295−0.2%ReducedHolders
Q1 202110,935,989$5.17B0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.